反応 #674303
ord-af896080e51a4cd89c4cdaee491ea0dd
反応方程式
反応物
試薬
反応条件
後処理
- 1その他The solution was sonicated at room temperature for 90 min (
- 2その他the temperature of sonication bath
- 3濃縮concentrated by rotavapor
- 4その他to give the residue which
- 5その他The layers were separated
- 6抽出The aqueous phase was extracted with DCM (3×30 mL)
- 7洗浄The combined organic phase was washed with brine (30 mL)
- 8乾燥dried over anhydrous Na2SO4
- 9濃縮concentrated
- 10その他to give pale yellow solid which
- 11その他was purified by CombiFlash [12 g silica gel column; (MeOH/NH4OH=10/1)/DCM: 0-20%]
実験手順
(R)-tert-butyl 2-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)-7-azaspiro[3.5]nonane-7-carboxylate (105 mg, 0.178 mmol, 1.0 equiv) was dissolved in formic acid (6 mL). The solution was sonicated at room temperature for 90 min (the temperature of sonication bath reached about 40° C. after 90 min). The solution was cooled to room temperature and concentrated by rotavapor to give the residue which was dissolved in EtOAc (20 mL). A solution of Na2CO3 (2.0 M, 20 mL) was added. The mixture was stirred at room temperature for 30 min. H2O (10 mL) was added. The layers were separated. The aqueous phase was extracted with DCM (3×30 mL). The combined organic phase was washed with brine (30 mL), dried over anhydrous Na2SO4, concentrated to give pale yellow solid which was purified by CombiFlash [12 g silica gel column; (MeOH/NH4OH=10/1)/DCM: 0-20%] to afford 77 mg (yield 88%) of (R)-5-(1-(7-azaspiro[3.5]nonan-2-yl)-1H-pyrazol-4-yl)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine as a off-white foam solid.